Alternate Health Officers

Alternate Health Officers report on all aspects of the company's key businesses and strategies, and is responsible for managing and communicating information to the public pertaining to the company's operations, managerial organization, and financial standing.

Our Officers

Dr. Michael Murphy, MD
Chairman and
Chief Executive Officer

Dr. Michael Murphy M.D. attended the University of Texas College of Pharmacy and the University of Texas Southwestern Medical School in Dallas, Texas. After medical school, he completed an internship in internal medicine and then a residency in anesthesiology where he served as chief resident for the Audie L. Murphy Memorial VA Hospital and the Bexar County Hospital in San Antonio, Texas. During his 30 plus years of private practice in pain medicine, he founded, operated and eventually sold multiple different health care related ventures. These include multiple ambulatory surgical centers, doing over 45,000 cases per year, 2 large surgical hospitals, an 80,000-square foot medical office campus, an imaging center, physical therapy center and a large medical laboratory. In addition to the medical ventures, he also helped found The Bank of San Antonio where he currently sits on the Board of Directors as well as a registered independent investment company. Dr. Murphy also spoke nationally for Medtronic Neurological and was their keynote speaker for their national sales conference. He has also taught physician practice management seminars across the country for many years. In addition, Dr. Murphy was the founder and Chairman of the Board of what is now one of the largest independent medical groups (anesthesiology) in the country.

Dr. Murphy has established himself as a serial entrepreneur and angel investor. He is also an active member of a group from all over the country that meets to discuss ways to give back to our communities and the world.

James Griffiths
Chief Financial Officer

Mr. Jim Griffiths is a current member of the Board of Trustees of the Center for Addiction and Mental Health ("CAMH") in Toronto, Jim has a Masters in Business Administration, is a chartered accountant, and has over 30 years of experience in the real estate development/financing industries. He was the Vice President Finance of Genstar Property Corporation and the President of First City Development Corp. He was also President and director of RealFund, Canada's first public Real Estate Investment Trust and Krystal Bond Inc.

During his career, he has had responsibility for real estate asset acquisitions and sales of over $2 billion. In addition he is very experienced in financing real estate and has negotiated and placed real estate loans in an amount exceeding $2.5 billion. Jim was a past director of Pinetree Capital Inc., the Canadian Institute of Public Real Estate Companies and was the Founding Chairman of the Association of Foreign Investors in U.S. Real Estate. He is currently a director of Allied Properties Real Estate Investment Trust, Enssolutions Group Inc., and Champion Partners and is President of KLC Capital Investment Corporation, which provides financial advisory services.

Marcelin O’Neill
Chief Compliance Officer

Marcelin O’Neill is currently a Director and CEO of Cervantes Capital Corp., and also presently the Chief Compliance Officer of Alternate Health Corp..  Ms. O’Neill was a Director of Alternate Health Corp. from October 2014 to February 2017.  Ms. O’Neill served as a Director of Jagercor Energy Corp. from December 2011 to May 2014, and as Chief Financial Officer and Corporate Secretary of Jagercor, from July 2013 to May 2014.   She served as a director of Brandenburg Energy Corp. from February 2008 to February 2013, and as Chief Financial Officer and Corporate Secretary from August 2010 to February 2013.  Ms. O'Neill served as the Vice President of Corporate Affairs of Mandalay Resources Corporation from April 2009 to March 2010, and from April 2007 until May 2008, she served as a director of Mandalay.  Since 1994 Ms. O'Neill has worked with such companies as Augusta Resource Corporation, Westcoast Energy Inc., and the Lundin Group.  In 1987, Ms. O'Neill graduated from the British Columbia Institute of Technology, where she studied Business Management, and has successfully completed the CSC and the CPH, both with honors.  Ms. O'Neill is the managing director of Accrete Consulting Inc., a company which provides corporate governance and management services to public companies.  With over 23 years of experience in public company management, Ms. O’Neill brings a varied scope of knowledge to the companies with which she works.

Michael Klipper
Chief Research
and Development Officer

Michael Klipper, a formulary chemist, entrepreneur, author, and fundraiser is the Co-Founder of Cannabinoid Science International Corp. (CSI), which functions as a scientific accelerator/incubator for Cannabis related research, development, and commercialization. It's was established to develop precision made Cannabinoid based formulary compounds that can be manufactured world-wide and made available to individuals in need of healing. By collaborating with leading researchers in Biochemistry, Physics, Computer Science (systems biology), and Healthcare Services; CSI is committed to developing scientifically proven treatments, educating regulatory agencies, healthcare professionals, and patients. This will essentially improve quality of life and health outcomes, while championing a paradigm shift in society well being. Michael is a respected member of the International Cannabinoid Research Society (ICRS).

Michael is also championing scientific research for healing with non-Cannabis therapies. Michael is Director of Business Development for Transforming Medicine (, as well as a Founding Board Member of Voices Against Brain Cancer ( (VABC), a 501(c)(3) committed to finding a cure for brain cancer and brain tumors by advancing scientific research and supporting patients, their families and caregivers afflicted with this devastating disease. Since its inception, Michael has held an active role on VABC's Granting Committee and has forged relationships with the leading neuro oncologists, surgeons, and researchers. In 2009, his role expanded to that of Chairman of VABC where under his leadership, millions have been raised to fund scientific research and support programs for the brain cancer community. Michael continues efforts in pioneering brain cancer treatments.

Michael was President & CEO of The Klipper Group, 1996-2013, a family of companies actively involved in formulary chemistry, developing chemical compounds, processes, and metering delivery devices. Under his leadership, the Klipper Group received the prestigious Champion Award from the United States Environmental Protection Agency (EPA), highest recognition, for developing Safer Detergents for The Environment. Michael is the co-author of Textile Laundering Technology, a publication recognized as the "bible" for the textile process industry. He was selected by Dr. Lynn Sehulster, Center for Disease Control, for "peer review" of revised "Guidelines for Environmental Infection Control in Health-Care Facilities" published by the CDC (2005). He was also the Principal Investigator in research establishing new process protocols for low temperature chlorine oxidation. Michael is the inventor of BIOZYME enzyme product and process, the Co-inventor of MICRO-OUNCE fluid and metering technology, and the inventor of COOLTERGENT 120, a commercial laundry detergent developed to successfully remove heavily soiled textiles at 120°F. Michael is a Graduate of Farleigh Dickenson University.

George Mull
Chief Legal

Bio coming soon.

Please feel free to contact us for more information.